GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » Research & Development

Imricor Medical Systems (ASX:IMR) Research & Development : A$12.64 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Imricor Medical Systems's Research & Development for the six months ended in Dec. 2024 was A$6.92 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was A$12.64 Mil.

Imricor Medical Systems Research & Development Historical Data

The historical data trend for Imricor Medical Systems's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems Research & Development Chart

Imricor Medical Systems Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 7.37 13.53 11.78 11.83 12.92

Imricor Medical Systems Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.16 5.84 5.98 5.72 6.92

Imricor Medical Systems Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$12.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imricor Medical Systems  (ASX:IMR) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Imricor Medical Systems Research & Development Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Imricor Medical Systems Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » Research & Development
Comparable Companies
ASX:AVR ASX:PNV ASX:EMV ASX:ARX ASX:4DX ASX:SOM ASX:IPD ASX:COV ASX:CMP ASX:MX1 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
400 Gateway Boulevard, Burnsville, MN, USA, 55337
Website
https://www.imricor.com
Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. Its principal business activities are to design, manufacture and sell MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems Headlines

No Headlines